Maurizio Martini
TitleCited byYear
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme
R Pallini, L Ricci-Vitiani, GL Banna, M Signore, D Lombardi, M Todaro, ...
Clinical Cancer Research 14 (24), 8205-8212, 2008
3062008
Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis
M Martini, M Ciccarone, G Garganese, C Maggiore, A Evangelista, ...
International journal of cancer 102 (4), 398-406, 2002
1662002
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ...
Clinical Cancer Research 15 (13), 4415-4422, 2009
1482009
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
R Pallini, L Ricci‐Vitiani, N Montano, C Mollinari, M Biffoni, T Cenci, ...
Cancer 117 (1), 162-174, 2011
1142011
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia
L Teofili, F Giona, M Martini, T Cenci, F Guidi, L Torti, G Palumbo, ...
Journal of Clinical Oncology 25 (9), 1048-1053, 2007
1032007
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas
A Cingolani, R Gastaldi, L Fassone, F Pierconti, ML Giancola, M Martini, ...
Journal of Clinical Oncology 18 (19), 3325-3330, 2000
1032000
Expression of EGFRvIII in glioblastoma: prognostic significance revisited
N Montano, T Cenci, M Martini, QG D'Alessandris, F Pelacchi, ...
Neoplasia (New York, NY) 13 (12), 1113, 2011
942011
The viral load of Epstein–Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma
S Hohaus, R Santangelo, M Giachelia, B Vannata, G Massini, A Cuccaro, ...
Clinical Cancer Research 17 (9), 2885-2892, 2011
872011
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
A Inno, M Di Salvatore, T Cenci, M Martini, A Orlandi, A Strippoli, ...
Clinical colorectal cancer 10 (4), 325-332, 2011
822011
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
D Rossi, S Rasi, V Spina, M Fangazio, S Monti, M Greco, C Ciardullo, ...
British journal of haematology 158 (3), 426-429, 2012
812012
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S Hohaus, M Giachelia, G Massini, G Mansueto, B Vannata, V Bozzoli, ...
Annals of oncology 20 (8), 1408-1413, 2009
812009
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior
F Pierconti, M Martini, F Pinto, T Cenci, S Capodimonti, A Calarco, ...
The Prostate 71 (3), 318-325, 2011
792011
Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results
JK Willmann, L Bonomo, AC Testa, P Rinaldi, G Rindi, KS Valluru, ...
Journal of Clinical Oncology 35 (19), 2133, 2017
762017
BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid…
ED Rossi, M Martini, S Capodimonti, CP Lombardi, A Pontecorvi, ...
Cancer cytopathology 121 (6), 291-297, 2013
762013
Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia
L Teofili, M Martini, M Luongo, A Di Mario, G Leone, V De Stefano, ...
Journal of clinical oncology 20 (20), 4249-4254, 2002
742002
Role of p16/INK4a in Gastrointestinal Stromal Tumor Progression
R Ricci, V Arena, F Castri, M Martini, N Maggiano, M Murazio, F Pacelli, ...
American journal of clinical pathology 122 (1), 35-43, 2004
732004
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis
M Martini, L Teofili, T Cenci, F Giona, L Torti, M Rea, R Fo, G Leone, ...
haematologica 93 (7), 1068-1071, 2008
722008
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation
L Teofili, M Martini, T Cenci, G Petrucci, L Torti, S Storti, F Guidi, G Leone, ...
Blood 110 (1), 354-359, 2007
722007
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases
L Teofili, M Martini, T Cenci, F Guidi, L Torti, F Giona, R Fo, G Leone, ...
International journal of cancer 123 (7), 1586-1592, 2008
702008
Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor…
L Teofili, M Martini, M Luongo, D Diverio, G Capelli, M Breccia, FL Coco, ...
Leukemia 17 (5), 919, 2003
702003
The system can't perform the operation now. Try again later.
Articles 1–20